Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
MIST	MILESTONE PHARMACEUTICALS INC	$144.79M	-2,372.70%	-85.10%	-70.24%	-73.30%	3.28	8.24	N/A	N/A	N/A
QCLS	Q/C TECHNOLOGIES INC	$15.58M	-121.40%	-48.90%	-25.40%	-419.50%	1.11	1.71	N/A	N/A	N/A
NVAX	NOVAVAX INC	$1.41B	-167.00%	25.50%	50.00%	71.10%	-8.53	2.27	91.80%	32.10%	35.22%
NMRA	NEUMORA THERAPEUTICS INC	$591.50M	-113.80%	-96.90%	-154.89%	-242.80%	0.35	6.85	N/A	N/A	N/A
DRMA	DERMATA THERAPEUTICS INC	$1.29M	-192.00%	-140.20%	N/A	-2,889.20%	0.28	N/A	N/A	N/A	N/A
NTLA	INTELLIA THERAPEUTICS INC	$1.42B	-57.20%	-44.60%	-53.61%	-51.60%	0.24	6.21	100.00%	-774.90%	-774.94%
APGE	APOGEE THERAPEUTICS INC	$4.76B	-39.10%	-36.90%	-42.80%	-46.30%	0.07	15.86	N/A	N/A	N/A
CGC	CANOPY GROWTH CORP	$411.87M	-52.90%	-32.70%	-32.28%	-40.00%	0.46	5.34	25.80%	-117.30%	-116.88%
CADL	CANDEL THERAPEUTICS INC	$309.08M	-29.20%	-22.60%	-26.21%	353.60%	0.17	8.25	N/A	N/A	N/A
MOVE	MOVANO INC	$9.56M	-398.80%	-165.30%	1,135.50%	3,692.40%	-4.27	0.70	-270.20%	-3,409.60%	-3,109.00%
IPSC	CENTURY THERAPEUTICS INC	$168.50M	-13.40%	-8.80%	-11.09%	-11.90%	0.39	6.25	100.00%	-23.40%	-21.79%
PTHS	PELTHOS THERAPEUTICS INC	$55.69M	-210.30%	-72.80%	-21.88%	-431.20%	1.17	2.01	68.70%	-318.40%	-300.30%
PDSB	PDS BIOTECHNOLOGY CORP	$33.21M	-209.00%	-83.30%	-150.77%	-287.10%	2.67	2.09	N/A	N/A	N/A
ARTV	ARTIVA BIOTHERAPEUTICS INC	$100.88M	-50.00%	-44.00%	-57.49%	-52.80%	0.15	11.65	N/A	N/A	N/A
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	$210.25M	-28.70%	-21.10%	-32.68%	-220.10%	0.26	7.86	100.00%	-68.30%	-83.92%
CTMX	CYTOMX THERAPEUTICS INC	$892.92M	44.50%	20.30%	24.11%	60.40%	0.47	3.64	100.00%	24.70%	24.87%
HCTI	HEALTHCARE TRIANGLE INC	$930.66k	-112.80%	-60.00%	-50.36%	-290.90%	0.59	2.03	13.10%	-48.90%	-38.63%
INBS	INTELLIGENT BIO SOLUTIONS INC	$7.71M	-197.90%	-99.20%	-89.49%	-470.70%	0.61	2.38	56.30%	-256.40%	-254.49%
GHRS	GH RESEARCH PLC	$991.85M	-15.80%	-15.30%	-14.53%	-71.20%	0.04	28.32	N/A	N/A	N/A
NUVL	NUVALENT INC	$7.43B	-39.50%	-35.70%	-42.75%	-44.00%	0.16	10.73	N/A	N/A	N/A
CHRS	COHERUS ONCOLOGY INC	$194.60M	-574.70%	34.90%	115.84%	139.50%	4.89	1.24	47.80%	185.40%	199.92%
CAPR	CAPRICOR THERAPEUTICS INC	$1.05B	-71.00%	-56.10%	-83.42%	-78.10%	0.51	3.59	100.00%	-736.60%	-736.62%
SENS	SENSEONICS HOLDINGS INC	$308.48M	-133.20%	-53.40%	-48.67%	-58.80%	0.79	6.23	41.10%	-217.60%	-197.45%
ALVO	ALVOTECH	$1.45B	-26.10%	5.30%	20.46%	10.40%	-8.97	1.42	55.60%	12.10%	39.44%
VVOS	VIVOS THERAPEUTICS INC	$14.20M	-351.30%	-87.40%	-93.94%	-180.60%	9.13	0.78	55.70%	-98.80%	-98.77%
DRTS	ALPHA TAU MEDICAL LTD	$634.42M	-51.20%	-38.20%	-31.98%	-37.50%	0.28	10.52	N/A	N/A	N/A
SRTS	SENSUS HEALTHCARE INC	$62.91M	-5.70%	-5.00%	-9.08%	-14.60%	0.14	7.38	48.00%	-8.40%	-13.13%
ZURA	ZURA BIO LTD	$397.29M	-48.20%	-38.30%	-54.26%	359.10%	0.24	5.58	N/A	N/A	N/A
ADTX	ADITXT INC	$339.58k	-757.20%	-156.60%	472.06%	-351.20%	-2.67	0.02	-1,111.20%	-710,498.70%	-703,444.47%
FBRX	FORTE BIOSCIENCES INC	$373.05M	-75.60%	-65.90%	-61.53%	-3,473.20%	0.15	7.34	N/A	N/A	N/A
AKAN	AKANDA CORP	$136.76k	-56.60%	-27.50%	-66.04%	-3,415.80%	0.88	1.26	9.60%	-619.50%	-619.14%
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	$749.22M	-42.60%	-13.10%	-11.90%	-16.40%	1.70	5.29	20.90%	-63.10%	-48.76%
AQST	AQUESTIVE THERAPEUTICS INC	$473.37M	N/A	-59.90%	-37.64%	-38.10%	-40.81	5.93	60.30%	-158.90%	-119.69%
HUMA	HUMACYTE INC	$213.49M	N/A	-27.90%	-39.90%	-24.80%	-20.26	1.62	60.50%	-2,353.20%	-1,674.35%
STXS	STEREOTAXIS INC	$194.12M	-597.20%	-55.60%	-93.69%	-298.10%	5.44	1.31	53.10%	-82.80%	-78.56%
PCSA	PROCESSA PHARMACEUTICALS INC	$4.94M	-301.40%	-217.30%	-221.71%	250,955.20%	0.30	3.76	N/A	N/A	N/A
VERU	VERU INC	$37.72M	-83.20%	-55.60%	-47.26%	-659.20%	0.28	5.16	N/A	N/A	N/A
TARA	PROTARA THERAPEUTICS INC	$252.75M	-35.10%	-32.50%	-39.27%	-63.70%	0.09	13.69	N/A	N/A	N/A
TENX	TENAX THERAPEUTICS INC	$77.92M	-43.20%	-41.50%	-45.03%	1,681.90%	0.07	15.58	N/A	N/A	N/A
FDMT	4D MOLECULAR THERAPEUTICS INC	$541.64M	-47.30%	-42.40%	-54.07%	-54.60%	0.15	8.42	100.00%	-174,314.20%	-174,314.17%
CGEM	CULLINAN THERAPEUTICS INC	$720.14M	-42.10%	-39.80%	-48.01%	-49.30%	0.07	10.45	N/A	N/A	N/A
STRO	SUTRO BIOPHARMA INC	$141.62M	N/A	-73.40%	-155.14%	-202.80%	-3.40	2.53	100.00%	-205.20%	-202.30%
ABVX	ABIVAX SA	$9.16B	N/A	N/A	N/A	N/A	0.28	7.86	N/A	N/A	N/A
CATX	PERSPECTIVE THERAPEUTICS INC	$360.54M	-39.10%	-33.20%	-39.26%	-49.80%	0.22	8.66	100.00%	-9,841.90%	-10,014.70%
BCYC	BICYCLE THERAPEUTICS PLC	$362.79M	-35.50%	-29.20%	-36.37%	-763.20%	0.24	10.66	100.00%	-884.50%	-891.54%
OKUR	ONKURE THERAPEUTICS INC	$32.52M	-95.80%	-86.90%	-121.50%	1,899.00%	0.10	11.45	N/A	N/A	N/A
XFOR	X4 PHARMACEUTICALS INC	$271.05M	-343.70%	-69.80%	-61.27%	-78.30%	1.65	5.65	83.20%	-279.90%	-252.51%
SRZN	SURROZEN INC	$210.26M	-5,313.30%	-116.50%	-119.80%	-835.10%	-5.00	13.15	100.00%	-6,400.70%	-6,400.73%
AURA	AURA BIOSCIENCES INC	$333.39M	-69.70%	-58.20%	-62.12%	-82.20%	0.21	9.04	N/A	N/A	N/A
QURE	UNIQURE NV	$1.35B	-373.70%	-35.70%	-20.62%	-22.70%	2.88	7.12	88.10%	-1,492.90%	-1,031.34%
GOSS	GOSSAMER BIO INC	$497.63M	N/A	-59.70%	-100.61%	-38.50%	-3.54	3.28	100.00%	-354.50%	-335.05%
NVCT	NUVECTIS PHARMA INC	$236.31M	-143.90%	-92.80%	-143.61%	243.20%	0.72	2.39	N/A	N/A	N/A
ORIC	ORIC PHARMACEUTICALS INC	$982.66M	-45.30%	-41.80%	-32.91%	-55.20%	0.06	14.65	N/A	N/A	N/A
NGNE	NEUROGENE INC	$269.21M	-29.80%	-27.50%	-31.17%	-38.50%	0.08	18.39	N/A	N/A	N/A
RVMD	REVOLUTION MEDICINES INC	$19.45B	-49.20%	-40.00%	-47.32%	-46.80%	0.41	8.05	N/A	N/A	N/A
STSS	SHARPS TECHNOLOGY INC	$50.24M	-90.80%	-85.70%	-23.60%	-94.60%	0.03	3.74	-718.70%	-34,070.10%	-33,385.77%
CELC	CELCUITY INC	$4.97B	-179.00%	-58.00%	-33.96%	-41.30%	3.07	12.26	N/A	N/A	N/A
OVID	OVID THERAPEUTICS INC	$101.83M	-63.70%	-46.10%	-63.68%	-62.50%	0.43	4.24	100.00%	-549.60%	-549.62%
ARAY	ACCURAY INC	$60.34M	-57.90%	-7.70%	-4.14%	-3.10%	7.39	1.47	27.70%	-8.20%	-2.36%
IMMX	IMMIX BIOPHARMA INC	$272.65M	-263.50%	-120.00%	-254.88%	547.00%	1.43	1.53	N/A	N/A	N/A
ATAI	ATAI BECKLEY NV	$1.38B	-107.90%	-78.60%	-68.03%	-104.70%	0.50	7.90	100.00%	-5,109.10%	-5,032.77%
MNPR	MONOPAR THERAPEUTICS	$362.30M	-25.70%	-24.80%	-13.73%	-155.60%	0.02	56.10	N/A	N/A	N/A
PMCB	PHARMACYTE BIOTECH INC	$6.60M	-25.80%	-22.10%	-13.00%	-22.30%	0.55	14.60	N/A	N/A	N/A
MIRA	MIRA PHARMACEUTICALS INC	$52.35M	-1,677.80%	-1,519.20%	-74.14%	-532.80%	0.01	90.53	N/A	N/A	N/A
RXST	RXSIGHT INC	$354.01M	-12.80%	-11.40%	-12.45%	-13.10%	0.12	12.74	75.00%	-25.10%	-25.08%
RAPP	RAPPORT THERAPEUTICS INC	$1.39B	-28.60%	-27.20%	-18.75%	-38.90%	0.05	36.37	N/A	N/A	N/A
DMAC	DIAMEDICA THERAPEUTICS INC	$453.07M	-83.30%	-73.60%	-61.70%	-90.10%	0.11	10.67	N/A	N/A	N/A
PYXS	PYXIS ONCOLOGY INC	$82.81M	-102.10%	-74.40%	-114.78%	-85.40%	0.54	4.29	100.00%	-3,442.80%	-3,509.47%
LUCD	LUCID DIAGNOSTICS INC	$177.61M	-781.30%	-169.50%	-197.32%	-1,081.40%	1.06	1.90	-58.10%	-1,496.80%	-1,210.75%
CLPT	CLEARPOINT NEURO INC	$385.99M	-114.30%	-48.10%	-42.95%	-72.10%	2.80	6.37	61.30%	-67.40%	-65.44%
OABI	OMNIAB INC	$246.16M	-23.10%	-20.60%	-22.59%	-84.50%	0.12	5.00	98.60%	-301.80%	-317.49%
INMB	INMUNE BIO INC	$37.22M	-172.00%	-134.50%	-191.87%	1,346.60%	0.31	4.17	100.00%	-99,774.00%	-99,774.00%
AMLX	AMYLYX PHARMACEUTICALS INC	$1.55B	-68.90%	-61.50%	-44.49%	-128.50%	0.09	13.70	100.00%	22,448.40%	22,543.91%
SPRB	SPRUCE BIOSCIENCES INC	$62.34M	-305.40%	-168.00%	-762.62%	955.90%	1.84	1.54	100.00%	-6,869.30%	-6,440.17%
KMTS	KESTRA MEDICAL TECHNOLOGIES LTD	$1.52B	-198.60%	-60.60%	-58.75%	-180.50%	0.50	5.47	46.40%	-186.90%	-166.90%
IMRX	IMMUNEERING CORP	$330.60M	-73.50%	-65.00%	-26.99%	-1,472.40%	0.06	24.00	N/A	N/A	N/A
CLYM	CLIMB BIO INC	$382.51M	-26.40%	-25.60%	-28.62%	-33.40%	0.03	18.38	N/A	N/A	N/A
YDES	YD BIOPHARMA LTD	$608.43M	N/A	-12.30%	-20.99%	401.50%	0.04	13.18	30.40%	-276.60%	-271.52%
DYN	DYNE THERAPEUTICS INC	$2.18B	-66.20%	-56.30%	-52.13%	-146.40%	0.25	13.47	N/A	N/A	N/A
TRDA	ENTRADA THERAPEUTICS INC	$421.18M	-26.40%	-22.10%	-26.87%	-25.40%	0.21	14.08	100.00%	-168.20%	-169.85%
COGT	COGENT BIOSCIENCES INC	$6.11B	-100.20%	-68.50%	-37.30%	-94.90%	0.47	14.24	N/A	N/A	N/A
CVKD	CADRENAL THERAPEUTICS INC	$10.19M	-279.50%	-204.50%	-525.99%	928.40%	0.50	3.02	N/A	N/A	N/A
TLX	TELIX PHARMACEUTICALS LTD	$2.15B	13.90%	5.20%	7.84%	27.90%	1.67	2.78	65.10%	6.40%	11.87%
RCUS	ARCUS BIOSCIENCES INC	$2.08B	-68.20%	-31.30%	-44.93%	-44.90%	1.23	3.65	100.00%	-142.10%	-138.33%
OMER	OMEROS CORP	$845.84M	N/A	-53.90%	-121.65%	-23.80%	-1.84	0.89	N/A	N/A	N/A
WHWK	WHITEHAWK THERAPEUTICS INC	$138.56M	-10.40%	-9.60%	-9.94%	-37.60%	0.06	16.76	89.20%	-108.60%	-108.58%
ANVS	ANNOVIS BIO INC	$63.08M	-153.50%	-125.50%	-184.94%	-8,454.30%	0.31	4.60	N/A	N/A	N/A
VNDA	VANDA PHARMACEUTICALS INC	$366.47M	-49.20%	-37.60%	-40.33%	-50.90%	0.49	2.39	94.00%	-102.00%	-64.16%
ABEO	ABEONA THERAPEUTICS INC	$273.12M	78.40%	48.00%	41.45%	86.10%	0.35	9.74	-22.00%	20,587.50%	21,650.75%
KRRO	KORRO BIO INC	$108.11M	-68.90%	-45.90%	-60.11%	-49.60%	0.63	6.71	100.00%	-1,199.50%	-1,198.11%
MOH	MOLINA HEALTHCARE INC	$6.99B	11.00%	3.00%	9.53%	14.50%	2.83	1.69	9.00%	1.00%	1.72%
TIL	INSTIL BIO INC	$58.26M	-53.00%	-31.80%	-32.91%	-22.50%	0.76	34.45	N/A	N/A	N/A
TSHA	TAYSHA GENE THERAPIES INC	$1.25B	-67.30%	-42.10%	-34.68%	-185.10%	0.45	10.48	100.00%	-1,583.70%	-1,582.50%
SXTC	CHINA SXT PHARMACEUTICALS INC	$1.94M	-50.30%	-30.90%	-41.06%	4,390.00%	0.30	4.37	654,226.10%	-4,820,590.80%	-4,550,441.85%
OLMA	OLEMA PHARMACEUTICALS INC	$1.55B	-41.50%	-37.60%	-48.25%	-50.60%	0.15	8.03	N/A	N/A	N/A
RNAC	CARTESIAN THERAPEUTICS INC	$175.52M	N/A	-12.60%	-13.29%	-27.00%	-11.40	10.67	100.00%	-4,638.60%	-4,371.40%
GNLX	GENELUX CORP	$97.41M	-129.30%	-97.40%	-160.49%	-169.50%	0.34	4.20	N/A	N/A	N/A
ASBP	ASPIRE BIOPHARMA HOLDINGS INC	$4.27M	N/A	-1,490.10%	158.11%	923.80%	-1.21	0.17	45.50%	-1,056,755.00%	-933,320.14%
RGNX	REGENXBIO INC	$407.01M	-78.30%	-34.50%	-33.89%	-26.00%	2.25	2.67	87.20%	-110.30%	-84.16%
PRAX	PRAXIS PRECISION MEDICINES INC	$8.20B	-66.90%	-60.30%	-79.49%	-115.20%	0.15	5.18	100.00%	-3,658.50%	-3,658.53%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	610	+1.46%	+0.32%	-0.48%	-29.81%	203.20x	5.16x	-23.77%	-9.51%	-6.53%	+67.37%	Strong Buy
Diagnostics & Research	56	-0.40%	-4.39%	-12.07%	+6.08%	16.70x	3.97x	-4.44%	+6.36%	+11.82%	+22.58%	Buy
Drug Manufacturers - General	20	+0.36%	+2.68%	+8.12%	+28.89%	43.99x	7.33x	+100.80%	+12.44%	+21.08%	+4.47%	Buy
Drug Manufacturers - Specialty & Generic	75	+1.04%	-0.27%	+0.71%	-27.50%	-166.20x	1.75x	+9.97%	+2.28%	+5.20%	+42.63%	Buy
Healthcare Plans	10	-0.35%	+4.19%	-12.63%	-24.67%	19.38x	1.91x	+11.67%	+3.66%	+8.52%	+20.65%	Buy
Health Information Services	54	+0.76%	-3.56%	-18.69%	-91.47%	27.39x	3.20x	+8.66%	+4.39%	+6.53%	+66.23%	Buy
Medical Care Facilities	50	-0.09%	+5.82%	+12.69%	-30.49%	16.89x	5.91x	-68.69%	+7.69%	+15.92%	+10.21%	Buy
Medical Devices	139	+1.82%	-1.81%	-5.06%	-84.07%	21.83x	3.65x	+11.89%	+7.22%	+9.67%	+41.83%	Strong Buy
Medical Distribution	10	+0.90%	+0.77%	+10.03%	+52.80%	32.39x	277.72x	-98.61%	+3.54%	+23.66%	+2.69%	Buy
Medical Instruments & Supplies	57	+0.57%	-0.94%	-3.87%	-14.92%	171.28x	3.06x	+9.60%	+8.37%	+10.83%	+23.32%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Feb 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Pediatrix Medical Group (NYSE:MD)

Pediatrix Medical Group (NYSE:MD) is the #1 top healthcare stock out of 1081 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pediatrix Medical Group (NYSE:MD) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: B, Financials: B, and AI: C.

Pediatrix Medical Group (NYSE:MD) has a Due Diligence Score of 44, which is 18 points higher than the healthcare sector average of 26. It passed 14 out of 33 due diligence checks and has strong fundamentals. Pediatrix Medical Group has seen its stock return 51.92% over the past year, overperforming other healthcare stocks by 105 percentage points.

Pediatrix Medical Group has an average 1 year price target of $21.33, a downside of -1.74% from Pediatrix Medical Group's current stock price of $21.71.

Pediatrix Medical Group stock has a consensus Hold recommendation according to Wall Street analysts. Of the 3 analysts covering Pediatrix Medical Group, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #2 top healthcare stock out of 1081 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: A, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 30, which is 4 points higher than the healthcare sector average of 26. It passed 10 out of 33 due diligence checks and has average fundamentals. Bioventus has seen its stock lose -19.35% over the past year, overperforming other healthcare stocks by 33 percentage points.

Bioventus has an average 1 year price target of $13.00, an upside of 55.13% from Bioventus's current stock price of $8.38.

Bioventus stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Bioventus, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the #3 top healthcare stock out of 1081 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Ironwood Pharmaceuticals (NASDAQ:IRWD) is: Value: A, Growth: B, Momentum: B, Sentiment: C, Safety: C, Financials: A, and AI: C.

Ironwood Pharmaceuticals (NASDAQ:IRWD) has a Due Diligence Score of 40, which is 14 points higher than the healthcare sector average of 26. It passed 13 out of 33 due diligence checks and has average fundamentals. Ironwood Pharmaceuticals has seen its stock return 139% over the past year, overperforming other healthcare stocks by 192 percentage points.

Ironwood Pharmaceuticals has an average 1 year price target of $6.50, an upside of 35.98% from Ironwood Pharmaceuticals's current stock price of $4.78.

Ironwood Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Ironwood Pharmaceuticals, 0% have issued a Strong Buy rating, 50% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 68 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 29.06%, which is 27 percentage points higher than the healthcare sector average of 2.26%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

2. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 9.1%, which is 7 percentage points higher than the healthcare sector average of 2.26%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 154.3% indicates that its high dividend yield might not be sustainable for the long-term.

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 7.81%, which is 6 percentage points higher than the healthcare sector average of 2.26%.

Oramed Pharmaceuticals's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.81% in the last day, and down -0.2% over the last week. Polaryx Therapeutics was the among the top gainers in the healthcare sector, gaining 64.32% yesterday.

Polaryx shares are trading higher after the company announced it selected a contract research organization for SOTERIA to evaluate PLX-200, across four different LSDs.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 86, which is 68 points higher than the healthcare sector average of 18. It passed 6 out of 7 valuation due diligence checks.

Embecta's stock has dropped -32.88% in the past year. It has overperformed other stocks in the healthcare sector by 20 percentage points.

2. Nutex Health (NASDAQ:NUTX)

Nutex Health (NASDAQ:NUTX) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Nutex Health has a valuation score of 57, which is 39 points higher than the healthcare sector average of 18. It passed 4 out of 7 valuation due diligence checks.

Nutex Health's stock has gained 53.58% in the past year. It has overperformed other stocks in the healthcare sector by 106 percentage points.

3. Organon & Co (NYSE:OGN)

Organon & Co (NYSE:OGN) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Organon & Co has a valuation score of 71, which is 53 points higher than the healthcare sector average of 18. It passed 5 out of 7 valuation due diligence checks.

Organon & Co's stock has dropped -52.97% in the past year. It has performed in line with other stocks in the healthcare sector.

Are healthcare stocks a good buy now?

57.82% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 39.3% over the next year.

6.59% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.93% of healthcare stocks are rated B (Buy), 46.95% are rated C (Hold), 25.03% are rated D (Sell), and 8.5% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 59.51x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Pediatrix Medical Group (NYSE:MD)

2. Bioventus (NASDAQ:BVS)

3. Ironwood Pharmaceuticals (NASDAQ:IRWD)

1. Dominari Holdings (NASDAQ:DOMH)

2. Spok Holdings (NASDAQ:SPOK)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Embecta (NASDAQ:EMBC)

2. Nutex Health (NASDAQ:NUTX)

3. Organon & Co (NYSE:OGN)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Pediatrix Medical Group (NYSE:MD)

2. Bioventus (NASDAQ:BVS)

3. Ironwood Pharmaceuticals (NASDAQ:IRWD)

1. Dominari Holdings (NASDAQ:DOMH)

2. Spok Holdings (NASDAQ:SPOK)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Embecta (NASDAQ:EMBC)

2. Nutex Health (NASDAQ:NUTX)

3. Organon & Co (NYSE:OGN)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.